Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > What is the success rate of clinical drug development?
View:
Post by Chianchin on Aug 07, 2023 4:13pm

What is the success rate of clinical drug development?

 
 
Despite this validated effort, the overall success rate of clinical drug development remains low at 10%–15%5, 6, 7. Such persistent high failure rate raises several questions: Why 90% of clinical drug development fails despite implementation of many successful strategies in the past several decades?
Comment by Chianchin on Aug 07, 2023 4:38pm
Despite this validated effort, the overall success rate of clinical drug development remains low at 10%–15%5, 6, 7. Such persistent high failure rate raises several questions: Why 90% of clinical drug development fails despite implementation of many successful strategies in the past several decades?
Comment by MrMugsy on Aug 07, 2023 6:49pm
Don't ask the question Chi-Chi ... answer it !!! Look at what this space really is - it's exploration. It's about finding something new that hasn't be found before. Some paths lead you astray while others lead to success. You don't know what you're going to find at the end - when all is said and done. Look at Big Pharma spending billions to develop drugs - what did they ...more  
Comment by Chianchin on Aug 10, 2023 3:26am
Mr micky mugsy, you have lost your shirt and all on ATE, nothing left to invest other than writing on this board with bS. Two Years ago  ATE did a reverse consolidation when it trades at $.50. 10 share became one share. So ATE traded arrounf $4.50. now it trades back at $50 again. By now you have lost over 90% of your money and you claim to know about investing. LOL
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities